6至59月龄年龄别体重Z评分严重偏低儿童营养治疗:三臂随机对照试验研究方案
该研究为在马里纳拉卫生区开展的前瞻性个体随机对照三臂试验,纳入6至59月龄、上臂围≥125 mm且年龄别体重Z评分(WAZ)<-3的儿童,比较不治疗、简化治疗与标准治疗3种方案;主要终点为2个月时WAZ连续测量值,并评估简化治疗相对不治疗的优效性及相对标准治疗的非劣效性(非劣效界值0.2 WAZ)。
要点
- 纳入标准为上臂围≥125 mm且WAZ<-3的6至59月龄儿童。
- 简化治疗每日1袋即食治疗食品(RUTF),至连续2次访视WAZ≥-3。
- 计划招募1397例,对照组209例,简化组与标准组各594例。
核心结论
- 该试验旨在生成治疗WAZ<-3但上臂围≥125 mm儿童获益的新证据,以指导营养不良治疗准入标准的选择并积累最有效治疗方案的证据。
研究设计与样本
- 前瞻性个体随机对照三臂试验,在马里纳拉卫生区开展。
- 纳入6至59月龄、上臂围≥125 mm且WAZ<-3的儿童,随机分为对照组、简化治疗组和标准治疗组。
- 计划共招募1397例儿童,其中对照组209例,简化治疗组和标准治疗组各594例。
主要发现
- 主要终点在2个月时测量,主要结局为WAZ连续测量值。
- 其他结局包括其他人体测量指标,次要终点在6个月时观察。
- 所有儿童先每两周随访1次共12周,之后每月随访1次至入组后6个月。
关键数值与推荐
- 对照组不接受治疗。
- 简化治疗组每日1袋即食治疗食品(RUTF),直至连续2次访视WAZ≥-3。
- 标准治疗组按体重别身高Z评分(WHZ)分类:WHZ<-3者每日200 kcal/kg直至连续2次访视WHZ≥-2;WHZ≥-3但<-2者每日1袋直至连续2次访视WHZ≥-2;WHZ≥-2者不接受治疗。
- 样本量旨在判定简化治疗相对不治疗的优效性及简化治疗相对标准治疗的非劣效性,非劣效界值为0.2 WAZ。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Admission criteria that treat children with low mid-upper-arm circumference (MUAC), and low weight-for-height z-score (WHZ) are not aligned with the evidence on which children are at risk of mortality. An analysis of community-based cohort data from Senegal found that a combination of weight-for-age (WAZ) and MUAC criteria identified all children at risk of near-term death associated with severe anthropometric deficits. This study will address whether children with WAZ <-3 but MUAC ≥125 mm benefit from therapeutic feeding with ready-to-use therapeutic foods (RUTF) and whether a simplified protocol is non-inferior to the weight-based standard protocol. METHODS: This is a prospective individually randomized controlled 3-arm trial conducted in the Nara health district in Mali. Children aged 6-59 months presenting with MUAC ≥125 mm and WAZ <-3 will be randomized to (1) control group receiving no treatment, (2) simplified treatment receiving 1 sachet of RUTF daily until WAZ ≥-3 for 2 visits, (3) standard treatment receiving RUTF according to WHZ category: (a) WHZ <-3 receive 200 kcal/kg/day until WHZ ≥-2 for 2 visits, (b) WHZ ≥-3 but <-2 receive 1 sachet daily until WHZ ≥-2 for 2 visits or (c) WHZ ≥-2 receive no treatment. All children will be followed up first fortnightly for 12 weeks and then monthly until 6 months post-enrolment. The primary endpoint will be measured at 2 months with the primary outcome being WAZ as a continuous measure. Other outcomes include other anthropometric measurements and a secondary endpoint will be observed at 6 months. A total of 1397 children will be recruited including 209 in the control and 594 in both the simplified and standard arms. The sample size should enable us to conclude on the superiority of the simplified treatment compared to no treatment and on the non-inferiority of the simplified treatment versus standard treatment with a margin of non-inferiority of 0.2 WAZ. DISCUSSION: This trial aims to generate new evidence on the benefit of treating children with WAZ <-3 but MUAC ≥125 mm in order to guide the choice of admission criteria to malnutrition treatment and build evidence on the most efficient treatment protocol. TRIAL REGISTRATION: This trial was registered at ClinicalTrials.gov: NCT05248516 on February 21, 2022.
引用
- Kangas ST, Ouédraogo CT, Tounkara M, et al. Nutritional treatment of children 6-59 months with severely low weight-for-age z-score: a study protocol for a 3-arm randomized controlled trial. Trials. 2024. PMID: 38191436. doi:10.1186/s13063-023-07890-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。